Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors

Modern Pathology

Volumn 27, Issue 7, 2014, Pages 936-944

  Larson, Allison R ^a   Dresser, Karen A ^b   Zhan, Qian ^a   Lezcano, Cecilia ^a   Woda, Bruce A ^b   Yosufi, Benafsha ^c   Thompson, John F ^c   Scolyer, Richard A ^c   Mihm, Martin C ^a   Shi, Yujiang G ^a   Murphy, George F ^a   Lian, Christine Guo ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

5 hydroxymethylcytosine; DNA methylation; dysplastic nevus; melanocytic lesion; melanoma

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; 5-HYDROXYMETHYLCYTOSINE; CYTOSINE;

ARTICLE; BASEMENT MEMBRANE; DERMIS; DYSPLASTIC NEVUS; EPIDERMIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; JUVENILE MELANOMA; KERATINOCYTE; MAJOR CLINICAL STUDY; MELANOCYTE; MELANOCYTIC NEVUS; NEVUS CELL; PRIORITY JOURNAL; TUMOR GROWTH; ADULT; AGED; ANALOGS AND DERIVATIVES; DNA METHYLATION; FEMALE; GENETICS; MALE; MELANOMA; MIDDLE AGED; NEVUS; PATHOLOGY; PRECANCER; SKIN TUMOR; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CYTOSINE; DNA METHYLATION; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEVUS; PRECANCEROUS CONDITIONS; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84903770977     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2013.224     Document Type: Article

References (18)

1. Lian CG, Murphy GF. Diagnostic implications of loss of 5-hydroxymethylcytosine for melanoma. Expert Rev Dermatol 2013;8: 99
2. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genetics 2002;3: 415
3. Tahiliani M, Koh KP, Shen Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009; 324: 930
4. Xu Y, Wu F, Tan L, et al. Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol Cell 2011;42: 451
5. Tan L, Shi YG. Tet family proteins and 5-hydroxymethylcytosine in development and disease. Development 2012;139: 1895
6. Lian CG, Xu Y, Ceol C, et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 2012;150: 1135
7. Haffner MC, Chaux A, Meeker AK, et al. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget 2011;2: 627
8. Konstandin N, Bultmann S, Szwagierczak A, et al. Genomic 5-hydroxymethylcytosine levels correlate with TET2 mutations and a distinct global gene expression pattern in secondary acute myeloid leukemia. Leukemia 2011;25: 1649
9. Kudo Y, Tateishi K, Yamamoto K, et al. Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Sci 2012;103: 670
10. Yang H, Liu Y, Bai F, et al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 2013; 32: 663
11. Li LX, Crotty KA, Scolyer RA, et al. Use of multiple cytometric markers improves discrimination between benign and malignant melanocytic lesions: A study of DNA microdensitometry, karyometry, argyrophilic staining of nucleolar organizer regions and MIB1-Ki67 immunoreactivity. Melanoma Res 2003;13: 581
12. Miedema J, Marron JS, Niethammer M, et al. Image and statistical analysis of melanocytic histology. Histopathology 2012;61: 436
13. Stolz W, Vogt T, Landthaler M, et al. Differentiation between malignant melanomas and benign melanocytic nevi by computerized DNA cytometry of imprint specimens. J Cutan Pathol 1994;21: 7
14. Scolyer RA, Murali R, McCarthy SW, et al. Histologically ambiguous (borderline) primary cutaneous melanocytic tumors: Approaches to patient management including the roles of molecular testing and sentinel lymph node biopsy. Arch Pathol Lab Med 2010;134: 1770
15. Scolyer R, Judge M, Evans A, et al. Data set for pathology reporting of cutaneous invasive melanoma recommendations from the International Collaboration on Cancer Reporting (ICCR). Amer J Surg Pathol 2013; 37: 1797-1814
16. Murphy GF, Mihm MC Jr. Recognition and evaluation of cytological dysplasia in acquired melanocytic nevi. Human Pathol 1999;30: 506
17. Elder DE, Murphy GF (eds). Melanocytic Tumors of the Skin. Armed Forces Institute of Pathology Washington, 2010
18. Zembowicz A, Scolyer RA. Nevus/Melanocytoma/ Melanoma: An emerging paradigm for classification of melanocytic neoplasmš Arch Pathol Lab Med 2011; 135: 300